These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

168 related items for PubMed ID: 23826416

  • 1. Gene and microRNA expression reveals sensitivity to paclitaxel in laryngeal cancer cell line.
    Xu CZ, Xie J, Jin B, Chen XW, Sun ZF, Wang BX, Dong P.
    Int J Clin Exp Pathol; 2013; 6(7):1351-61. PubMed ID: 23826416
    [Abstract] [Full Text] [Related]

  • 2. Potential biomarkers for paclitaxel sensitivity in hypopharynx cancer cell.
    Xu CZ, Shi RJ, Chen D, Sun YY, Wu QW, Wang T, Wang PH.
    Int J Clin Exp Pathol; 2013; 6(12):2745-56. PubMed ID: 24294361
    [Abstract] [Full Text] [Related]

  • 3. Array analysis for potential biomarker of gemcitabine identification in non-small cell lung cancer cell lines.
    Zhang HH, Zhang ZY, Che CL, Mei YF, Shi YZ.
    Int J Clin Exp Pathol; 2013; 6(9):1734-46. PubMed ID: 24040438
    [Abstract] [Full Text] [Related]

  • 4. Regulation of microtubule-associated protein tau (MAPT) by miR-34c-5p determines the chemosensitivity of gastric cancer to paclitaxel.
    Wu H, Huang M, Lu M, Zhu W, Shu Y, Cao P, Liu P.
    Cancer Chemother Pharmacol; 2013 May; 71(5):1159-71. PubMed ID: 23423488
    [Abstract] [Full Text] [Related]

  • 5. MicroRNA-133b targets glutathione S-transferase π expression to increase ovarian cancer cell sensitivity to chemotherapy drugs.
    Chen S, Jiao JW, Sun KX, Zong ZH, Zhao Y.
    Drug Des Devel Ther; 2015 May; 9():5225-35. PubMed ID: 26396496
    [Abstract] [Full Text] [Related]

  • 6. MicroRNA-196a is a putative diagnostic biomarker and therapeutic target for laryngeal cancer.
    Saito K, Inagaki K, Kamimoto T, Ito Y, Sugita T, Nakajo S, Hirasawa A, Iwamaru A, Ishikura T, Hanaoka H, Okubo K, Onozaki T, Zama T.
    PLoS One; 2013 May; 8(8):e71480. PubMed ID: 23967217
    [Abstract] [Full Text] [Related]

  • 7. MiR-634 sensitizes nasopharyngeal carcinoma cells to paclitaxel and inhibits cell growth both in vitro and in vivo.
    Peng X, Cao P, He D, Han S, Zhou J, Tan G, Li W, Yu F, Yu J, Li Z, Cao K.
    Int J Clin Exp Pathol; 2014 May; 7(10):6784-91. PubMed ID: 25400759
    [Abstract] [Full Text] [Related]

  • 8. Differential altered expression of let-7a and miR-205 tumor-suppressor miRNAs in different subtypes of breast cancer under treatment with Taxol.
    Asghari F, Haghnavaz N, Shanehbandi D, Khaze V, Baradaran B, Kazemi T.
    Adv Clin Exp Med; 2018 Jul; 27(7):941-945. PubMed ID: 30019863
    [Abstract] [Full Text] [Related]

  • 9. MicroRNA-34a Attenuates Paclitaxel Resistance in Prostate Cancer Cells via Direct Suppression of JAG1/Notch1 Axis.
    Liu X, Luo X, Wu Y, Xia D, Chen W, Fang Z, Deng J, Hao Y, Yang X, Zhang T, Zhou L, Wu Y, Wang Q, Xu J, Hu X, Li L.
    Cell Physiol Biochem; 2018 Jul; 50(1):261-276. PubMed ID: 30282072
    [Abstract] [Full Text] [Related]

  • 10. Human cancer cell line microRNAs associated with in vitro sensitivity to paclitaxel.
    Chen N, Chon HS, Xiong Y, Marchion DC, Judson PL, Hakam A, Gonzalez-Bosquet J, Permuth-Wey J, Wenham RM, Apte SM, Cheng JQ, Sellers TA, Lancaster JM.
    Oncol Rep; 2014 Jan; 31(1):376-83. PubMed ID: 24220856
    [Abstract] [Full Text] [Related]

  • 11. miR-30a-5p enhances paclitaxel sensitivity in non-small cell lung cancer through targeting BCL-2 expression.
    Xu X, Jin S, Ma Y, Fan Z, Yan Z, Li W, Song Q, You W, Lyu Z, Song Y, Shi P, Liu Y, Han X, Li L, Li Y, Liu Y, Ye Q.
    J Mol Med (Berl); 2017 Aug; 95(8):861-871. PubMed ID: 28487996
    [Abstract] [Full Text] [Related]

  • 12. Integrated miRNA and mRNA expression analysis uncovers drug targets in laryngeal squamous cell carcinoma patients.
    Lapa RML, Barros-Filho MC, Marchi FA, Domingues MAC, de Carvalho GB, Drigo SA, Kowalski LP, Rogatto SR.
    Oral Oncol; 2019 Jun; 93():76-84. PubMed ID: 31109699
    [Abstract] [Full Text] [Related]

  • 13. Circ-RNF111 contributes to paclitaxel resistance in breast cancer by elevating E2F3 expression via miR-140-5p.
    Zang H, Li Y, Zhang X, Huang G.
    Thorac Cancer; 2020 Jul; 11(7):1891-1903. PubMed ID: 32445273
    [Abstract] [Full Text] [Related]

  • 14. Paclitaxel exposure downregulates miR-522 expression and its downregulation induces paclitaxel resistance in ovarian cancer cells.
    Miyamoto M, Sawada K, Nakamura K, Yoshimura A, Ishida K, Kobayashi M, Shimizu A, Yamamoto M, Kodama M, Hashimoto K, Kimura T.
    Sci Rep; 2020 Oct 07; 10(1):16755. PubMed ID: 33028939
    [Abstract] [Full Text] [Related]

  • 15. Down-regulated expression of miR-134 contributes to paclitaxel resistance in human ovarian cancer cells.
    Shuang T, Wang M, Shi C, Zhou Y, Wang D.
    FEBS Lett; 2015 Oct 07; 589(20 Pt B):3154-64. PubMed ID: 26363097
    [Abstract] [Full Text] [Related]

  • 16. MiR-1204 sensitizes nasopharyngeal carcinoma cells to paclitaxel both in vitro and in vivo.
    Peng X, Cao P, Li J, He D, Han S, Zhou J, Tan G, Li W, Yu F, Yu J, Li Z, Cao K.
    Cancer Biol Ther; 2015 Oct 07; 16(2):261-7. PubMed ID: 25756509
    [Abstract] [Full Text] [Related]

  • 17. High microRNA-23a expression in laryngeal squamous cell carcinoma is associated with poor patient prognosis.
    Zhang XW, Liu N, Chen S, Wang Y, Zhang ZX, Sun YY, Qiu GB, Fu WN.
    Diagn Pathol; 2015 Apr 03; 10():22. PubMed ID: 25879432
    [Abstract] [Full Text] [Related]

  • 18. Morin promotes prostate cancer cells chemosensitivity to paclitaxel through miR-155/GATA3 axis.
    Li B, Jin X, Meng H, Hu B, Zhang T, Yu J, Chen S, Guo X, Wang W, Jiang W, Wang J.
    Oncotarget; 2017 Jul 18; 8(29):47849-47860. PubMed ID: 28599307
    [Abstract] [Full Text] [Related]

  • 19. MicroRNA profile of paclitaxel-resistant serous ovarian carcinoma based on formalin-fixed paraffin-embedded samples.
    Li X, Lu Y, Chen Y, Lu W, Xie X.
    BMC Cancer; 2013 Apr 30; 13():216. PubMed ID: 23627607
    [Abstract] [Full Text] [Related]

  • 20. cDNA microarray analysis of isogenic paclitaxel- and doxorubicin-resistant breast tumor cell lines reveals distinct drug-specific genetic signatures of resistance.
    Villeneuve DJ, Hembruff SL, Veitch Z, Cecchetto M, Dew WA, Parissenti AM.
    Breast Cancer Res Treat; 2006 Mar 30; 96(1):17-39. PubMed ID: 16322897
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.